We are live on ! Find out more
CII

CR Intrinsic Investors Portfolio holdings

AUM $2.67B
1-Year Est. Return 28.43%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+28.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.3B
AUM Growth
-$926M
Cap. Flow
-$1.11B
Cap. Flow %
-48.28%
Top 10 Hldgs %
16.52%
Holding
471
New
127
Increased
50
Reduced
84
Closed
205

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$48.9M
2
ZTS icon
Zoetis
ZTS
+$41.8M
3
HD icon
Home Depot
HD
+$39.8M
4
VZ icon
Verizon
VZ
+$35M
5
RNR icon
RenaissanceRe
RNR
+$34M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 29.95%
2 Industrials 13.22%
3 Technology 9.79%
4 Materials 7.88%
5 Healthcare 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEL icon
151
TE Connectivity
TEL
$63.9B
$5.51M 0.24%
+100,000
New +$5.26M
BSFT
152
DELISTED
BroadSoft, Inc.
BSFT
$5.45M 0.24%
199,441
+135,763
+213% +$4.02M
MNST icon
153
Monster Beverage
MNST
$89.3B
$5.42M 0.24%
960,000
-840,000
-47% -$4.13M
LLL
154
DELISTED
L3 Technologies, Inc.
LLL
$5.34M 0.23%
+50,000
New +$5M
IVZ icon
155
Invesco
IVZ
$14.2B
$5.28M 0.23%
145,000
+15,000
+12% +$509K
DANG
156
DELISTED
E-COMMERCE CHINA DANGDANG INC SPNSRD ADS REP COM CL A (CYM)
DANG
$5.25M 0.23%
550,000
+318,500
+138% +$3.02M
EEM icon
157
PUT
iShares MSCI Emerging Markets ETF
EEM
$30B
$5.22M 0.23%
+125,000
New +$5.23M
HTWR
158
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$5.17M 0.22%
55,000
+5,000
+10% +$423K
GMED icon
159
Globus Medical
GMED
$11.6B
$5.04M 0.22%
250,000
-25,000
-9% -$464K
TT icon
160
Trane Technologies
TT
$108B
$4.93M 0.21%
80,000
-20,160
-20% -$1.11M
VC icon
161
Visteon
VC
$2.83B
$4.91M 0.21%
+60,000
New +$4.63M
YELP icon
162
Yelp
YELP
$1.34B
$4.9M 0.21%
+71,001
New +$4.7M
TRAK
163
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
$4.86M 0.21%
+101,001
New +$4.2M
ULTA icon
164
Ulta Beauty
ULTA
$23.6B
$4.83M 0.21%
+50,000
New +$5.86M
WMB icon
165
Williams Companies
WMB
$88.9B
$4.82M 0.21%
+125,000
New +$4.5M
DAL icon
166
CALL
Delta Air Lines
DAL
$59B
$4.81M 0.21%
+175,000
New +$4.7M
BLOX
167
DELISTED
Infoblox Inc
BLOX
$4.79M 0.21%
+145,000
New +$5.68M
UFS
168
DELISTED
DOMTAR CORPORATION (New)
UFS
$4.72M 0.2%
+100,000
New +$4.34M
BMS
169
DELISTED
Bemis
BMS
$4.71M 0.2%
+115,000
New +$4.52M
C icon
170
Citigroup
C
$229B
$4.69M 0.2%
+90,000
New +$4.55M
EJ
171
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
$4.52M 0.2%
+323,100
New +$3.26M
TWTR
172
DELISTED
Twitter, Inc.
TWTR
$4.52M 0.2%
+71,001
New +$3.53M
MSGS icon
173
Madison Square Garden
MSGS
$9.55B
$4.32M 0.19%
105,150
-35,050
-25% -$1.43M
SWC
174
DELISTED
Stillwater Mining Co
SWC
$4.32M 0.19%
+350,000
New +$3.94M
B
175
DELISTED
Barnes Group Inc.
B
$4.21M 0.18%
110,000

Similar funds

CR Intrinsic Investors's Q4 2013 Portfolio in Review

As of Q4 2013, CR Intrinsic Investors held 471 positions worth $2.3B, down 29% from $3.23B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

CR Intrinsic Investors withdrew a net $1.11B in Q4 2013, closing 205 positions and reducing 84 holdings. Its most notable exit was Intuitive Surgical, an estimated $48.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 30% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, CR Intrinsic Investors opened a new position in Crown Castle worth $38.6M.

  • CR Intrinsic Investors's largest Q4 2013 buy was Crown Castle: 525,000 shares worth $38.6M.
  • CR Intrinsic Investors added most to Charter Communications in Q4 2013, an estimated $23.9M increase.
  • CR Intrinsic Investors's biggest Q4 2013 reduction was Zoetis, cutting an estimated $41.8M.
  • CR Intrinsic Investors fully exited Intuitive Surgical in Q4 2013, selling an estimated $48.9M.
  • CR Intrinsic Investors's ten largest holdings make up 17% of its $2.3B portfolio in Q4 2013.
  • CR Intrinsic Investors opened 127 new positions and closed 205 in Q4 2013.
  • CR Intrinsic Investors's portfolio value fell 29% quarter-over-quarter to $2.3B.

Based on CR Intrinsic Investors's 13F filing for Q4 2013, filed 14 Feb 2014.